Press Releases

All Releases
Aug 01, 2013
AngioDynamics to Present at 33rd Annual Canaccord Growth Conference
ALBANY, N.Y. , Aug. 1, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, is scheduled to present at the 33 rd Annual Canaccord Growth Conference on
Jul 11, 2013
AngioDynamics Reports Fiscal 2013 Fourth Quarter Financial Results
Net sales of $90 million GAAP net loss of $0.02 per share; Adjusted (Non-GAAP) net income of $0.07 per share Adjusted EBITDA Grows 56% to $12.3 million Operating cash flow of $10.8 million versus $1 million of cash used in prior year Company Introduces Financial Guidance for FY 2014 ALBANY, N.Y.
May 14, 2013
AngioDynamics to Present at UBS Global Healthcare Conference
ALBANY, N.Y. , May 14, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, is scheduled to present at the UBS Global Healthcare Conference on Tuesday, May
Mar 08, 2013
AngioDynamics to Present at Barclays Global Healthcare Conference
ALBANY, N.Y. , March 8, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, is scheduled to present at the Barclays Global Healthcare Conference on Tuesday,
Feb 13, 2013
AngioDynamics to Present at RBC Capital Markets Healthcare Conference
ALBANY, N.Y. , Feb. 13, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, is scheduled to present at the RBC Capital Markets Global Healthcare Conference
Feb 01, 2013
AngioDynamics Completes Acquisition of Microsulis Medical
ALBANY, N.Y. , Feb. 1, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today said it has completed the previously announced acquisition of certain
Jan 15, 2013
AngioDynamics to Host Investor and Analyst Day on January 23, 2013
ALBANY, N.Y. , Jan. 15, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that it will host an investor and analyst meeting on Wednesday,
Displaying 161 - 180 of 649